Skip to main content

Larson Financial Group LLC

Position in TGTX — Tg Therapeutics, Inc.

CIK 1731061 ST LOUIS, MO

Position in TGTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$400,622
+$151,805 QoQ
Shares Held
7,292
-2.6% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#265
of 425 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in TGTX Over Time

Shares Held

Position Value (USD)

Derivatives in TGTX

reported options exposure · as of Dec 31, 2025
CallValue
$300
CallShares
300
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Larson Financial Group LLC holds $5,564,070 across 194 Biotechnology names. TGTX ranks #3 (7.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 TGTX
Tg Therapeutics, Inc.
This page
7,292 $400,622

All Filings in TGTX

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $400,622 7,292
2026-03-31 $248,817 7,490
2025-12-31 $300 300
2025-12-31 $213,558 7,164
2025-09-30 $254,392 7,042
2025-09-30 $1,939 300
2025-06-30 $245,127 6,811
2025-03-31 $22,514 571
2024-12-31 $10,354 344